Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Kracker

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Immunology|December 14, 2024
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled studyJohn Whalen, Anita Chandra, Sven Kracker, et al.
Frontiers in Immunology|May 15, 2025
Case Report: Activated PI3-kinase-δ syndrome and ovarian malignancies: a case series from the European ESID-APDS registryMaria Pia Esposto, Nizar Mahlaoui, Hassan Abolhassani, et al.
Frontiers in Pediatrics|July 12, 2021
Two Monogenetic Disorders, Activated PI3-Kinase-δ Syndrome 2 and Smith-Magenis Syndrome, in One Patient: Case Report and a Literature Review of Neurodevelopmental Impact in Primary Immunodeficiencies Associated With Disturbed PI3K SignalingNidia Moreno-Corona, Loïc Chentout, Lucie Poggi, et al.
Oncotarget|November 5, 2017
Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cellsFranziska Auer, Deborah Ingenhag, Stefan Pinkert, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2014
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndromeSven Kracker, James Curtis, Mohammad A A Ibrahim, et al.
Journal of Human Immunity|May 8, 2026
Ribosomal RNA processing impairments in a B cell immunodeficient patient with WDR75 variantsNidia Moreno-Corona, Alice Valagussa, Lucie Poggi, et al.
The Journal of Experimental Medicine|September 21, 2019
Concomitant <i>PIK3CD</i> and <i>TNFRSF9</i> deficiencies cause chronic active Epstein-Barr virus infection of T cellsRémy Rodriguez, Benjamin Fournier, Debora Jorge Cordeiro, et al.
Blood|May 31, 2011
Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemiaJulia Hauer, Charles Mullighan, Estelle Morillon, et al.
The Journal of Experimental Medicine|March 14, 2023
A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiencyRomane Thouenon, Loïc Chentout, Nidia Moreno-Corona, et al.
The Journal of Allergy and Clinical Immunology|May 2, 2015
Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutationDavid Buchbinder, Jeffrey R Stinson, Diane J Nugent, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Immunology|December 14, 2024
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled studyJohn Whalen, Anita Chandra, Sven Kracker, et al.
Frontiers in Immunology|May 15, 2025
Case Report: Activated PI3-kinase-δ syndrome and ovarian malignancies: a case series from the European ESID-APDS registryMaria Pia Esposto, Nizar Mahlaoui, Hassan Abolhassani, et al.
Frontiers in Pediatrics|July 12, 2021
Two Monogenetic Disorders, Activated PI3-Kinase-δ Syndrome 2 and Smith-Magenis Syndrome, in One Patient: Case Report and a Literature Review of Neurodevelopmental Impact in Primary Immunodeficiencies Associated With Disturbed PI3K SignalingNidia Moreno-Corona, Loïc Chentout, Lucie Poggi, et al.
Oncotarget|November 5, 2017
Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cellsFranziska Auer, Deborah Ingenhag, Stefan Pinkert, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2014
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndromeSven Kracker, James Curtis, Mohammad A A Ibrahim, et al.
Journal of Human Immunity|May 8, 2026
Ribosomal RNA processing impairments in a B cell immunodeficient patient with WDR75 variantsNidia Moreno-Corona, Alice Valagussa, Lucie Poggi, et al.
The Journal of Experimental Medicine|September 21, 2019
Concomitant <i>PIK3CD</i> and <i>TNFRSF9</i> deficiencies cause chronic active Epstein-Barr virus infection of T cellsRémy Rodriguez, Benjamin Fournier, Debora Jorge Cordeiro, et al.
Blood|May 31, 2011
Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemiaJulia Hauer, Charles Mullighan, Estelle Morillon, et al.
The Journal of Experimental Medicine|March 14, 2023
A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiencyRomane Thouenon, Loïc Chentout, Nidia Moreno-Corona, et al.
The Journal of Allergy and Clinical Immunology|May 2, 2015
Mild B-cell lymphocytosis in patients with a CARD11 C49Y mutationDavid Buchbinder, Jeffrey R Stinson, Diane J Nugent, et al.
Pageof 7